期刊文献+

雷珠单抗玻璃体腔注射治疗新生血管性年龄相关黄斑变性一例 被引量:1

下载PDF
导出
摘要 患者,女,71岁,2013年3月因右眼视物遮挡1个月来诊,就诊时最佳矫正视力(best corrected visual acuity,BCVA)0.3,裂隙灯显微镜下可见晶状体皮质局限性楔状混浊,间接检眼镜检查可见黄斑区视网膜下盘状出血,荧光素眼底血管造影(fundus fluorescine angiography,FFA)及吲哚青绿血管造影(indocyanine green angiography,ICGA)检查可见黄斑中心凹区脉络膜新生血管(choroidal neovascularization,CNV)性高荧光(图1).临床诊断为右眼新生血管性年龄相关黄斑变性(age-related macular degeneration,AMD),给予0.5 mg雷珠单抗玻璃体腔注射。
作者 哈文静
出处 《中华实验眼科杂志》 CAS CSCD 北大核心 2015年第9期827-828,共2页 Chinese Journal Of Experimental Ophthalmology
  • 相关文献

参考文献3

二级参考文献35

  • 1Xin Wang,Ying Zhang,Mao-Nian Zhang.Complement factor B polymorphism(rs641153) and susceptibility to age-related macular degeneration: evidence from published studies[J].International Journal of Ophthalmology(English edition),2013,6(6):861-867. 被引量:1
  • 2杨文炯.回族人口的分布及其城市化水平的比较分析——基于第五次人口普查资料[J].回族研究,2006(4):88-97. 被引量:20
  • 3Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med, 2006,355 : 1419-1431.
  • 4Cheng Y, Huang L, Li X, et al. Genetic and functional dissection of ARMS2 in age-related macular degeneration and polypoidal choroidal vaseulopathy[J/OL]. PLoS One, 2013,8 : E53665 [ 2013-01-09 ]. http://www, plosone, org/article/info% 3Adoi%2F10. 1371 52Fjournal. pone. 0053665.
  • 5Jiang J, Huang L, Yu W, et al. Overexpression of HTRA1 leads to down-regulation of fibronectin and functional changes in RF/6A cells and HUVECs[J/OL]. PLoS ONE,2012,7: E46115 [2012-10-08] : http://www, plosone, org/article/info% 3Adoi% 2F10. 1371 %2Fjournal. pone. 0046115.
  • 6Li, Xiaoxin: Polypoidal Choroidal Retinopathy in the 5th Edition of RETINA, vol 71,p 1285, Elsevier, 2013.
  • 7CATT Research Group, Martin DF, Maguire MG, et al. Ranibizumab and bevaeizumab for neovaseular age-related maeular degeneration. N Engl J Med,2011,364: 1897-1908.
  • 8Ranibizumab and bevacizumab for treatment of neovascular age- related macular degeneration: two-year results, Ophthalmology, 2012,119 : 1388-1398.
  • 9Schmidt-Erfurth UM, Richard G, Augustin A, et al. Guidance for the treatment of neovascular age-related macular degeneration. Acta Ophthalmol Scand, 2007,85:486-494.
  • 10Heimes B, Lommatzsch A, Zeimer M, et al. Long-term visual course after anti-VEGF therapy for exudative AMD in clinical practice evaluation of the German reinjeetion scheme. Grade's Arch Clin Exp Ophthalmol, 2011, 249 : 639-644.

共引文献64

同被引文献4

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部